| |
These materials are important and require your immediate attention. They require Shareholders of Columbia Care Inc. to make an important decision. If you are in doubt as to how to make such decision, please contact your financial, legal or other professional advisor. If you have any questions or require more information with regard to the transactions described herein or procedures for voting, please contact the Company’s proxy solicitation agent, Morrow Sodali, at 1-888-999-2785 toll free in North America, or call collect outside North America at 1-289-695-3075 or by email at assistance@morrowsodali.com.
|
| |
|
(signed) “Nicholas Vita”
Nicholas Vita
Director and Chief Executive Officer |
| | | |
| | | | BY ORDER OF THE BOARD | |
| | | |
(signed) “Nicholas Vita”
Nicholas Vita
Director and Chief Executive Officer |
|
| | | | | 1 | | | |
| SUMMARY | | | | | 13 | | |
| | | | | 23 | | | |
| | | | | 26 | | | |
| | | | | 27 | | | |
| | | | | 27 | | | |
| | | | | 27 | | | |
| | | | | 27 | | | |
| | | | | 28 | | | |
| | | | | 29 | | | |
| | | | | 29 | | | |
| | | | | 30 | | | |
| | | | | 31 | | | |
| | | | | 31 | | | |
| | | | | 32 | | | |
| | | | | 32 | | | |
| | | | | 32 | | | |
| | | | | 37 | | | |
| | | | | 38 | | | |
| | | | | 46 | | | |
| | | | | 51 | | | |
| | | | | 51 | | | |
| | | | | 51 | | | |
| | | | | 54 | | | |
| | | | | 56 | | | |
| | | | | 56 | | | |
| | | | | 56 | | | |
| | | | | 58 | | | |
| | | | | 59 | | | |
| | | | | 64 | | | |
| | | | | 64 | | | |
| | | | | 64 | | | |
| | | | | 65 | | | |
| | | | | 65 | | | |
| | | | | 72 | | | |
| | | | | 74 | | |
| | | | | 75 | | | |
| | | | | 76 | | | |
| | | | | 76 | | | |
| | | | | 77 | | | |
| | | | | 78 | | | |
| | | | | 80 | | | |
| | | | | 80 | | | |
| | | | | 81 | | | |
| | | | | 81 | | | |
| | | | | 83 | | | |
| | | | | 86 | | | |
| | | | | 86 | | | |
| | | | | 86 | | | |
| | | | | 86 | | | |
| | | | | 87 | | | |
| | | | | 91 | | | |
| | | | | 97 | | | |
| | | | | 97 | | | |
| | | | | 99 | | | |
| | | | | 100 | | | |
| | | | | 108 | | | |
| | | | | 117 | | | |
| | | | | 117 | | | |
| | | | | 117 | | | |
| | | | | 117 | | | |
| | | | | 117 | | | |
| | | | | 118 | | | |
| | | | | 118 | | | |
| APPROVAL | | | | | 119 | | |
| | | | | 120 | | | |
| | | | | 121 | | |
| | | | | A-1 | | | |
| | | | | B-1 | | | |
| | | | | C-1 | | | |
| | | | | D-1 | | | |
| | | | | E-1 | | | |
| | | | | F-1 | | | |
| | | | | G-1 | | | |
| | | | | H-1 | | | |
| | | | | I-1 | | | |
| | | | | J-1 | | | |
| | | | | K-1 | | |
| | | | | | | | | |
Securities of Columbia Care Beneficially Owned, Directly or Indirectly, over which Control or Direction is Exercised(1)
|
| |||||||||||||||||||||||||||||||||||||||||||||
|
Name and
Position(s) / Relationship with Columbia Care |
| |
Number of
Columbia Care Common Shares Held(2) |
| |
Number of
Columbia Care PV Shares Held(3) |
| |
Percentage
of Voting Rights of Columbia Care Shares(4) |
| |
Number of
Columbia Care Options Held(5) |
| |
Number of
Columbia Care Warrants Held(6) |
| |
Number of
Columbia Care Convertible Notes Held(7) |
| |
Percentage of
Columbia Care RSUs Held(8) |
| |
Percentage of
Columbia Care PSUs Held(9) |
| |
Total Estimated
Value of Consideration to be Received from the Arrangement(10) |
| |||||||||||||||||||||||||||
|
Nicholas Vita,
Chief Executive Officer and Director |
| | | | 36,283,801 | | | | | | — | | | | | | 9.10% | | | | | | — | | | | | | — | | | | | | — | | | | | | 9.36% | | | | | | 29.55% | | | | | $ | 95,545,145.49 | | |
|
Michael Abbott,
Executive Chairman and Director |
| | | | 481,550 | | | | | | — | | | | | | 0.12% | | | | | | — | | | | | | — | | | | | | — | | | | | | 7.32% | | | | | | 26.85% | | | | | $ | 11,186,526.94 | | |
|
Frank Savage,
Director |
| | | | 106,987 | | | | | | — | | | | | | 0.03% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.23% | | | | | | 0.00% | | | | | $ | 329,015.60 | | |
|
James A.C. Kennedy,
Director |
| | | | 98,618 | | | | | | 18,234.28 | | | | | | 0.48% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.04% | | | | | | 0.00% | | | | | $ | 4,431,522.38 | | |
|
Jonathan P. May,
Director |
| | | | 89,388 | | | | | | 29,467.67 | | | | | | 0.76% | | | | | | — | | | | | | 60,775 | | | | | | — | | | | | | 0.25% | | | | | | 0.00% | | | | | $ | 7,068,103.53 | | |
|
Jeff Clarke,
Director |
| | | | 453,039 | | | | | | 47.29 | | | | | | 0.11% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.23% | | | | | | 0.00% | | | | | $ | 1,135,204.72 | | |
|
Alison Worthington,
Director |
| | | | 43,257 | | | | | | — | | | | | | 0.01% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.23% | | | | | | 0.00% | | | | | $ | 182,546.91 | | |
|
Julie Hill,
Director |
| | | | — | | | | | | — | | | | | | 0.00% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.35% | | | | | | 0.00% | | | | | $ | 124,694.89 | | |
|
Philip Goldberg,
Director |
| | | | 7,760,627 | | | | | | — | | | | | | 1.95% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.55% | | | | | | 0.00% | | | | | $ | 18,035,117.08 | | |
|
David Hart,
Chief Operating Officer |
| | | | 1,035,419 | | | | | | 746.92 | | | | | | 0.28% | | | | | | — | | | | | | — | | | | | | — | | | | | | 5.25% | | | | | | 9.48% | | | | | $ | 7,401,746.85 | | |
|
Lars Boesgaard,(11)
Former Chief Financial Officer |
| | | | 48,866 | | | | | | — | | | | | | 0.01% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.00% | | | | | | 0.00% | | | | | $ | 112,307.22 | | |
|
Dr. Rosemary Mazanet,
Chief Scientific Officer |
| | | | 1,286,858 | | | | | | 186.74 | | | | | | 0.33% | | | | | | — | | | | | | — | | | | | | — | | | | | | 2.31% | | | | | | 4.31% | | | | | $ | 5,412,559.21 | | |
|
Bryan Olson,
Chief People and Administrative Officer |
| | | | 397,698 | | | | | | 248.97 | | | | | | 0.11% | | | | | | — | | | | | | — | | | | | | — | | | | | | 2.60% | | | | | | 4.51% | | | | | $ | 3,555,917.64 | | |
|
Guy Hussussian,
Chief Data Officer |
| | | | 131,070 | | | | | | 31.13 | | | | | | 0.03% | | | | | | — | | | | | | — | | | | | | — | | | | | | 1.23% | | | | | | 2.79% | | | | | $ | 1,835,245.51 | | |
|
Jesse Channon,
Chief Growth Officer |
| | | | 270,417 | | | | | | — | | | | | | 0.07% | | | | | | — | | | | | | — | | | | | | — | | | | | | 3.89% | | | | | | 4.97% | | | | | $ | 3,763,460.52 | | |
|
Derek Watson,
Chief Financial Officer |
| | | | — | | | | | | — | | | | | | 0.00% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.00% | | | | | | 0.00% | | | | | $ | 731,736.00 | | |
|
David Sirolly,
Chief Legal Officer and General Counsel |
| | | | — | | | | | | — | | | | | | 0.00% | | | | | | — | | | | | | — | | | | | | — | | | | | | 0.46% | | | | | | 0.45% | | | | | $ | 1,002,549.94 | | |